The U.S. Food and Drug Administration is preparing to unveil measures that would significantly streamline the approval process for vaping products and nicotine pouches, according to a Wall Street Journal report citing people familiar with the matter. The agency is expected to revisit a 2021 rule outlining requirements for new tobacco product applications, with plans to simplify scientific study requirements and shorten review timelines to allow more products to gain authorization.

The move reflects growing pressure from tobacco companies on the Trump administration to create a faster, more transparent FDA authorization pathway. Last month, the FDA approved marketing for three new JUUL2 e-cigarette products — part of a broader series of nicotine product approvals the agency says may offer safer alternatives to traditional cigarettes.

Key Takeaways:

• The FDA is expected to revisit its 2021 tobacco application requirements rule
• Simplified scientific study requirements and faster review timelines are under consideration
• The Trump administration frames the effort as keeping nicotine away from kids while offering adult smokers safer alternatives
• During Trump's first term, his administration moved to pull flavored e-cigarettes from shelves to curb youth vaping

Why it matters: A faster FDA approval process for nicotine alternatives could reshape the tobacco and vaping market — but it also raises public health concerns about youth access to nicotine products, a tension the administration will need to carefully navigate.